Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
COVID-19: Maintaining quality control in testing times
With the onset of the COVID-19 pandemic, UKAS highlights the importance of maintaining quality control in testing times.
Bioquell’s rapid bio-decontamination service (RBDS) is effective against COVID-19
Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.
COVID-19 and crisis management: Reflecting upon challenges faced in the public sector
Dr Phillip Whiteman, Lecturer in Public Policy at the University of Birmingham, reflects on how the public sector has responded to the initial challenges of the COVID-19 pandemic.
COVID-19: The time for mental healthcare reform is now
Jennifer Oroilidis and Marie Fallon-Kund, from Mental Health Europe, argue that in light of COVID-19, the time for mental healthcare reform is now.
Will the UK learn from COVID-19 mistakes affecting vulnerable communities?
Family law Barrister Paula Rhone-Adrien speaks about the suffering of vulnerable people in the wake of COVID-19 mistakes by the UK.
How could we distribute a COVID-19 vaccine fairly and effectively?
Professor Behzad Samii, professor of operations and supply chain management at Vlerick Business School, discusses how to fairly circulate a COVID-19 vaccine.
Next Generation EU: Will the COVID-19 aid package work?
Experts say the post-pandemic rebuild needs to be sustainable: Next Generation EU is a COVID-19 aid package that promises to be green.
Reducing obesity and improving health during the COVID-19 pandemic
Following a report by PHE which reviewed how different factors such as obesity have affected COVID-19 risk and outcomes - Nutritionist Zoe Davies from Action on Sugar and Action on Salt shares insights into their new evidence-based plan.
Changing workplace landscape: How the COVID-19 pandemic has altered our way of working
Here, PLACEmaking assess what the post-pandemic workplace will look like, as organisations have been forced to become much more adaptable.
Re-imagining our urban future in light of COVID-19
Anna Lisa Boni, Secretary General, EUROCITIES enlightens us on the salient points when it comes to re-imagining our urban future in light of the COVID-19 pandemic.
Reviving the UK’s local economies in light of COVID-19
Gordon Mole, Head of Business and Employability at Fife Council and a Director of the Institute of Economic Development, shares his thoughts on reviving the UK’s local economies in light of COVID-19.
COVID-19: A moment for legalising medical cannabis?
Here, Josh Smith talks us through the current pandemic and the recent history underlying the fight for legalising medical cannabis.
10% of COVID-19 patients with diabetes die within 7 days of hospitalisation
New research has found that one in ten COVID-19 patients with diabetes dies within seven days of hospital admission.
Robotic Process Automation can help the public sector battle COVID-19
Teemu Vieruaho, Head of Intelligent Automation, Digital Workforce, discusses how Robotic Process Automation (RPA) can help fight the public sector’s battle against COVID-19.
COVID-19 recasts internet as a utility for every home
Jorg Welters, Partner at Reply, explores how the telecommunications sector has grown amid the COVID-19 crisis after broadband is perceived to be essential to surviving lockdown.
How will COVID-19 impact US-China trade relations?
Gidon Gautel, China Foresight Project Coordinator at LSE IDEAS, discusses how COVID-19 could impact US-China trade relations as the economy attempts to recover.
Company culture post-COVID-19 – How will yours change?
Helen Astill, MD Cherington HR Ltd, explores how company culture will be affected as businesses emerge from the COVID-19 pandemic.
Japan and EU work on strategic partnership for COVID-19 pandemic
President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.
Could placenta cells save patients with severe COVID-19?
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
Dementia gene doubles risk of developing severe COVID-19
Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.